CervoMed Inc. (CRVO)

NASDAQ: CRVO · Real-Time Price · USD

8.85

-0.35 (-3.80%)

At close: Sep 12, 2025, 4:00 PM EDT

8.77

-0.08 (-0.90%)

After-hours: Sep 12, 2025, 7:54 PM EDT

CervoMed Employees

CervoMed had 15 employees as of December 31, 2024. The number of employees increased by 7 or 87.50% compared to the previous year.

Employees

15

Change (1Y)

7

Growth (1Y)

87.50%

Revenue / Employee

$518,465

Profits / Employee

-$1,507,460

Market Cap

81.89M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	15	7	87.50%
Dec 31, 2023	8	4	100.00%
Dec 31, 2022	4	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

CRVO News

9 days ago - CervoMed to Participate in Upcoming Investor Conferences - GlobeNewsWire
6 weeks ago - CervoMed's Dementia Data Show Slowed Disease Progression - Benzinga
6 weeks ago - CervoMed Announces 32-Week Data from RewinD-LB Trial Extension Phase Showing Neflamapimod's Sustained Effect on Slowing Clinical Progression in Patients with Dementia with Lewy Bodies and Associated Reduction in a Key Plasma Biomarker of Neurodegeneration - GlobeNewsWire
2 months ago - CervoMed Announces Late-Breaking Presentations at Alzheimer's Association® International Congress 2025 - GlobeNewsWire
4 months ago - CervoMed Reports First Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewsWire
5 months ago - Biotech Stocks Q1 2025 Recap: Winners And Underperformers - Seeking Alpha
6 months ago - CervoMed Announces Oral Presentation at 19th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurologic Disorders (AP/PD™) - GlobeNewsWire
6 months ago - CervoMed: Extension Study Data In Dementia With Lewy Bodies Is Potentially Exciting, With Caveats - Seeking Alpha